市场调查报告书
商品编码
1466593
数位 PCR 市场:按产品类型、技术、应用和最终用户划分 - 2024-2030 年全球预测Digital PCR Market by Product Type (Instruments, Reagents and Consumables, Services), Technology (BEAMing Digital PCR, Droplet Digital PCR), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年数位PCR市场规模为56.4亿美元,预计2024年将达62亿美元,2030年将达112.5亿美元,复合年增长率为10.35%。
数位 PCR (dPCR) 是一种先进的分子生物学方法,用于对核酸进行绝对定量,涉及将样本细分为许多包含零个或一个模板分子的单独小反应。这种划分允许对核酸丰度进行离散测量,使 dPCR 成为检测稀有序列、量化突变和执行绝对定量的强大工具,而无需标准曲线。与qPCR技术相比,dPCR市场的成长主要是由于其卓越的准确性、敏感度和特异性,在临床诊断、个人化医疗和突变检测中发挥重要作用。此外,癌症研究、感染疾病诊断和作物检测对遗传物质精确定量的需求不断增长,正在推动 dPCR 应用的扩展。但由于dPCR设备及相关耗材成本较高,小型实验室及研究机构可能不愿意采用。此外,该技术复杂,需要熟练的人员,这增加了营运成本,并对市场成长构成挑战。然而,dPCR 技术与用于基因型鉴定和突变检测的 CRISPR 应用的整合提供了巨大的成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 56.4亿美元 |
预计年份 [2024] | 62亿美元 |
预测年份 [2030] | 112.5亿美元 |
复合年增长率(%) | 10.35% |
产品类型对高通量、精密定量设备的需求不断增加
数位PCR 市场的设备部分包括将样本分割成数千至数百万个液滴,对每个液滴进行PCR,然后分析这些液滴以确定遗传物质的存在和数量,包括专为这些液滴设计的分析仪、PCR 设备和热迴圈仪。这些仪器对于需要高灵敏度的应用至关重要,例如检测稀有等位基因、量化病毒量和检验次世代定序仪资料。试剂和耗材对于确保数位 PCR 实验的效率、可靠性和重现性至关重要。此类别包括广泛的产品,包括预混液、萤光标记探针和专用针对数位 PCR 优化的引子。此外,微孔盘、晶片和卡盒等消耗品设计为一次性使用,以防止交叉污染。数位 PCR 服务部门为缺乏内部执行数位 PCR 的资源或专业知识的研究人员和实验室提供从实验设计到资料分析的全面支援。这些服务包括测定设计、样品製备和自订分析。
应用 dPCR 在疾病检测与监测的重要性
在临床研究中,dPCR 主要因其定量准确度高、灵敏度高以及检测低水平病原体、微小残留疾病和基因突变的能力而被采用。 dPCR 的可靠性对于液态切片、感染疾病检测和肿瘤学研究至关重要。传染病检查中的 dPCR 提供了一种检测和量化传染性病原体的可靠方法,确保及时、准确地诊断病毒和细菌感染。在肿瘤学检测中,dPCR 能够检测与癌症相关的突变并定量血液中的肿瘤 DNA,为癌症诊断和治疗决策提供宝贵的见解。在移植诊断领域,dPCR有助于准确监测移植受者血液中的供体器官DNA,对于移植排斥的早期检测和指南免疫抑制治疗具有重要意义。
数位 PCR 由于其在水、土壤和空气样本中特定微生物和病毒病原体检测和定量方面的高精度而在环境监测中得到重要应用。 dPCR 能够在无需事先孵育的情况下分析复杂的环境样本,并将自己定位为监测水质、空气传播的病原体和土壤健康的重要工具。数位PCR广泛应用于基因作物(GMO)检测,因为它可以高精度地检测和量化作物和食品中的基因改造序列。高灵敏度可以准确测定基因改造生物含量,这对于标籤合规性和消费者安全至关重要。
区域洞察
在美洲,强大的研究基础设施、大型製药和生物技术公司的存在以及对医疗保健和诊断的大量投资主要推动了数位 PCR 技术的采用和实施。对肿瘤学研究的投资和对感染疾病诊断的关注进一步推动了该地区对 dPCR 的需求,从而导致全球市场显着增长。欧洲、中东和非洲地区的市场引进多种多样,因为每个国家都有不同的经济实力、技术力和医疗保健系统。由于製药和生物技术研究领域的进步,加上支持基因组研究的政府政策,欧洲的采用率很高。中东和非洲正在成长,但普及缓慢,很大程度上受到基础设施和资金有限的阻碍。然而,医疗保健投资的增加以及对先进诊断解决方案意识的提高预计将推动这些地区 dPCR 市场的成长。由于医疗保健基础设施的快速开拓、生物技术和药物研究投资的增加以及对精准医疗的兴趣日益浓厚,亚太地区的 dPCR 市场增长最快。此外,人口成长和慢性病盛行率上升导致采用先进的诊断技术,包括 dPCR。
FPNV定位矩阵
FPNV定位矩阵对于评估数位PCR市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对数位 PCR 市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1. 数位PCR市场规模及预测是多少?
2.数位PCR市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.数位PCR市场的技术趋势和法规结构是什么?
4.数位PCR市场主要厂商的市场占有率是多少?
5.进入数位PCR市场合适的型态和策略手段是什么?
[180 Pages Report] The Digital PCR Market size was estimated at USD 5.64 billion in 2023 and expected to reach USD 6.20 billion in 2024, at a CAGR 10.35% to reach USD 11.25 billion by 2030.
Digital PCR (dPCR) is an advanced molecular biology technique for the absolute quantification of nucleic acids, which includes subdividing the sample into many individual, smaller reactions that contain either zero or one template molecule. This partitioning allows for discrete measurement of nucleic acid amounts, making dPCR a powerful tool for detecting rare sequences, quantifying mutations, and providing absolute quantification without the need for standard curves. The growth of the dPCR market is primarily driven by its superior accuracy, sensitivity, and specificity compared to qPCR technologies, making it important for clinical diagnostics, personalized medicine, and mutation detection. Additionally, the rising demand for precise quantification of genetic materials for cancer research, infectious disease diagnosis, and GMO detection fuels the expansion of dPCR applications. However, the high cost of dPCR instruments and related consumables can deter small laboratories or research institutions from its adoption. The complexity of the technology also requires skilled personnel, adding to operational costs and posing challenges to market growth. However, the integration of dPCR technologies with CRISPR applications for genotyping and mutation detection offers significant growth opportunities.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.64 billion |
Estimated Year [2024] | USD 6.20 billion |
Forecast Year [2030] | USD 11.25 billion |
CAGR (%) | 10.35% |
Product Type: Growing demand for high-throughput and precise quantification instruments
The instruments segment in the digital PCR market encompasses analyzers, PCR machines, and the thermocycler designed for the partitioning of samples into thousands, or even millions, of droplets, conducting PCR in each partition and then analyzing these droplets to determine the presence or quantity of genetic material. These instruments are essential for applications requiring high sensitivity, such as detecting rare alleles, quantifying viral load, and validating next-generation sequencing data. Reagents and consumables are critical in ensuring the efficiency, reliability, and reproducibility of digital PCR experiments. This category encompasses a broad range of products, including master mixes, fluorescence-labeled probes, and primers specifically optimized for digital PCR. Additionally, consumables such as microplates, chips, or cartridges are designed for single-use to prevent cross-contamination. The digital PCR services sector provides comprehensive support ranging from experimental design to data analysis, catering to researchers and laboratories lacking the resources or expertise to run digital PCR in-house. These services include assay design, sample preparation, and custom analysis.
Application: Higher significance of dPCR for disease detection and monitoring
In clinical research, dPCR is primarily employed for its high precision in quantification, sensitivity, and ability to detect low-level pathogens, minimal residual disease, and genetic variations. The reliability of dPCR makes it indispensable for liquid biopsy, infectious disease detection, and oncology studies. Digital PCR is used in blood screening for detecting minimal traces of genetic material in blood samples, thereby aiding in the early diagnosis and monitoring of diseases. dPCR in infectious disease testing offers a robust method for detecting and quantifying infectious pathogens, ensuring timely and accurate diagnosis of viral and bacterial infections. In oncology testing, dPCR enables the detection of cancer-associated mutations and the quantification of tumor DNA in blood, providing valuable insights for cancer diagnosis and treatment decisions. In the field of transplant diagnostics, dPCR facilitates the precise monitoring of donor organ DNA in transplant recipients' blood, which is critical for the early detection of transplant rejection and guiding immunosuppression therapy.
Digital PCR finds significant application in environmental monitoring owing to its accuracy in detecting and quantifying specific microbial and viral pathogens in water, soil, and air samples. Its capability to analyze complex environmental samples without the need for prior culturing positions dPCR as a critical tool for monitoring water quality, airborne pathogens, and soil health. Digital PCR is extensively applied in genetically modified organisms (GMOs) testing for its high precision in detecting and quantifying genetically modified sequences in crops and food products. Its high sensitivity allows for accurate GMO content determination, which is critical for labeling compliance and consumer safety.
Regional Insights
In the Americas, the adoption and implementation of digital PCR technology are primarily driven by the strong research infrastructure, the presence of major pharmaceutical and biotechnology companies, and substantial investments in healthcare and diagnostics. Investments in oncology research and the focus on infectious disease diagnostics have further propelled the demand for dPCR in the region, resulting in significant market growth within the global landscape. The EMEA region shows a diverse market adoption owing to varying economic, technological, and healthcare system strengths across different countries. Europe showcases higher adoption rates, driven by advancements in pharmaceutical and biotech research sectors, coupled with supportive government policies favoring genomic research. The Middle East and Africa, while growing, exhibit a slower adoption rate, mainly restrained by limited infrastructure and funding. However, increased investments in healthcare and growing awareness about advanced diagnostics solutions are expected to catalyze the dPCR market growth in these areas. Asia-Pacific is witnessing the fastest growth in the digital PCR market, attributed to rapidly developing healthcare infrastructures, rising investments in biotechnology and pharmaceutical research, and increasing focus on precision medicine. Additionally, the growing population and rising prevalence of chronic diseases have led to the adoption of advanced diagnostic technologies, including dPCR.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Digital PCR Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital PCR Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Digital PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accumax, Agilent Technologies, Inc., Analytik Jena GmbH by Endress+Hauser, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, ELITechGroup by Bruker Corp., Eppendorf AG, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, JN MedSys, Merck Sharp & Dohme Corp., PerkinElmer, Inc., Precigenome LLC, Promega Corporation, Qiagen N.V., RainSure Scientific, Roche Holding AG, Stem Genomics, Stilla Technologies, Takara Bio, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Digital PCR Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital PCR Market?
3. What are the technology trends and regulatory frameworks in the Digital PCR Market?
4. What is the market share of the leading vendors in the Digital PCR Market?
5. Which modes and strategic moves are suitable for entering the Digital PCR Market?